دورية أكاديمية

Gut Microbiota in Monozygotic Twins Discordant for Parkinson's Disease.

التفاصيل البيبلوغرافية
العنوان: Gut Microbiota in Monozygotic Twins Discordant for Parkinson's Disease.
المؤلفون: Bolliri C; Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy.; Clinical Nutrition Unit, ASST-Pini-CTO, Milan, Italy., Fontana A; Department for Sustainable Food Process (DiSTAS), Università Cattolica del Sacro Cuore, Cremona, Italy., Cereda E; Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Barichella M; Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy.; Clinical Nutrition Unit, ASST-Pini-CTO, Milan, Italy., Cilia R; Fondazione IRCCS Istituto Neurologico Carlo Besta, Parkinson and Movement Disorders Unit, Milan, Italy., Ferri V; Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy.; Clinical Nutrition Unit, ASST-Pini-CTO, Milan, Italy., Caronni S; Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy.; Clinical Nutrition Unit, ASST-Pini-CTO, Milan, Italy., Calandrella D; Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy.; Parkinson Institute Milan, ASST-Pini-CTO, Milan, Italy., Morelli L; Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy., Pezzoli G; Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy.; Parkinson Institute Milan, ASST-Pini-CTO, Milan, Italy.
المصدر: Annals of neurology [Ann Neurol] 2022 Oct; Vol. 92 (4), pp. 631-636. Date of Electronic Publication: 2022 Aug 04.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8249 (Electronic) Linking ISSN: 03645134 NLM ISO Abbreviation: Ann Neurol Subsets: MEDLINE
أسماء مطبوعة: Publication: New York, NY : Wiley-Liss
Original Publication: Boston, Little, Brown.
مواضيع طبية MeSH: Gastrointestinal Microbiome*/genetics , Parkinson Disease*/genetics , Parkinson Disease*/pathology, Bile Acids and Salts ; Feces ; Humans ; Twins, Monozygotic
مستخلص: Differences in gut microbiota between Parkinson's disease patients and controls seem to depend on multiple-frequently unmeasured-confounders. Monozygotic twins offer a unique model for controlling several factors responsible for interpersonal variation in gut microbiota. Fecal samples from 20 monozygotic twin pairs (n = 40) discordant for Parkinson's disease were studied (metagenomic shotgun analysis). Paired data analysis detected minimal differences in bacterial taxa abundance at species level (Bacteroides pectinophilus [p = 0.037], Bifidobacterium pseudocatenulatum [p = 0.050], and Bifidobacterium catenulatum [p = 0.025]) and in predicted metabolic pathways (primary bile acid biosynthesis [p = 0.037]). Additional studies are warranted to understand the role of gut microbiota in the pathogenesis of Parkinson's disease. ANN NEUROL 2022;92:631-636.
(© 2022 American Neurological Association.)
References: Keshavarzian A, Engen P, Bonvegna S, Cilia R. The gut microbiome in Parkinson's disease: a culprit or a bystander? Prog Brain Res 2020;252:357-450. https://doi.org/10.1016/bs.pbr.2020.01.004.
Cilia R, Piatti M, Cereda E, et al. Does gut microbiota influence the course of Parkinson's disease? A 3-year prospective exploratory study in de novo patients. J Parkinsons Dis 2021;11:159-170.
Barichella M, Severgnini M, Cilia R, et al. Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism. Mov Disord 2019;34:396-405.
Goldman SM, Kamel F, Ross GW, et al. Peptidoglycan recognition protein genes and risk of Parkinson's disease. Mov Disord 2014;29:1171-1180.
Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 2001;57:S34-S38.
https://theromefoundation.org/rome-iv/rome-iv-criteria/.
Hoehn M, Yahr M. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
Chong J, Liu P, Zhou G, Xia J. Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data. Nat Protoc 2020;15:799-821.
Goodrich JK, Waters JL, Poole AC, et al. Human genetics shape the gut microbiome. Cell 2014;159:789-799.
Berer K, Gerdes LA, Cekanaviciute E, et al. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci USA 2017;114:10719-10724.
Aho VTE, Houser MC, Pereira PAB, et al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease. Mol Neurodegener 2021;16:6.
Forsyth CB, Shannon KM, Kordower JH, et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One 2011;6:e28032.
Minato T, Maeda T, Fujisawa Y, et al. Progression of Parkinson's disease is associated with gut dysbiosis: two-year follow-up study. PLoS One 2017;12:e0187307.
Li P, Killinger BA, Ensink E, et al. Gut microbiota dysbiosis is associated with elevated bile acids in Parkinson's disease. Metabolites 2021;11:29.
Romano S, Savva GM, Bedarf JR, et al. Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis 2021;7:27.
المشرفين على المادة: 0 (Bile Acids and Salts)
تواريخ الأحداث: Date Created: 20220719 Date Completed: 20220920 Latest Revision: 20221107
رمز التحديث: 20221213
DOI: 10.1002/ana.26454
PMID: 35852145
قاعدة البيانات: MEDLINE
الوصف
تدمد:1531-8249
DOI:10.1002/ana.26454